Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections
- PMID: 15183240
- DOI: 10.1016/j.jhin.2004.03.021
Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections
Abstract
Risk factors for multi-drug resistant Pseudomonas aeruginosa (MDRP) infections were investigated using a case-control study design involving MDRP patients (N = 44) and controls (N = 68). A retrospective cohort study was performed to study the predictive factors of clinical outcome in MDRP patients. Multivariate analysis demonstrated that previous exposure to imipenem/meropenem [odds ratio (OR), 44.8] and mechanical ventilation (OR 8.2) were risk factors for nosocomial infections of MDRP. Of 44 cases of MDRP infections, 20 patients died directly from P. aeruginosa infections. Pulsed-field gel electrophoresis (PFGE) analysis on serial isolates from three patients showed that profiles of isolates from the same patient were closely related or indistinguishable. Multivariate analysis demonstrated that patients with adverse clinical outcomes were more likely to have been treated with mechanical ventilation (OR 12.8), and more likely to have MDRP resistance patterns that did not change during treatments (OR 26.5). We concluded that mechanical ventilation and previous exposure to imipenem/meropenem were independent risk factors for MDRP infections, while mechanical ventilation and antibiotic resistance switch were predictive factors of outcomes of MDRP infections.
Copyright 2004 The Hospital Infection Society
Similar articles
-
[Risk factors and clinical outcomes of nosocomial infections caused by multidrug resistant Pseudomonas aeruginosa].Zhonghua Jie He He Hu Xi Za Zhi. 2004 Jan;27(1):31-5. Zhonghua Jie He He Hu Xi Za Zhi. 2004. PMID: 14989823 Chinese.
-
Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.Am J Infect Control. 2008 Dec;36(10):e13-8. doi: 10.1016/j.ajic.2008.07.006. Am J Infect Control. 2008. PMID: 19084158 Clinical Trial.
-
Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.Am J Infect Control. 2006 May;34(4):188-92. doi: 10.1016/j.ajic.2005.11.010. Am J Infect Control. 2006. PMID: 16679175
-
Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.Pharmacotherapy. 2005 Oct;25(10):1353-64. doi: 10.1592/phco.2005.25.10.1353. Pharmacotherapy. 2005. PMID: 16185180 Review.
-
[Biochemical and genetical mechanisms in emergence of multidrug-resistant Pseudomonas aeruginosa (MDRP)].Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:457-62. Nihon Rinsho. 2007. PMID: 17455662 Review. Japanese. No abstract available.
Cited by
-
A systems-level approach for investigating Pseudomonas aeruginosa biofilm formation.PLoS One. 2013;8(2):e57050. doi: 10.1371/journal.pone.0057050. Epub 2013 Feb 22. PLoS One. 2013. PMID: 23451140 Free PMC article.
-
Impact of piperacillin resistance on the outcome of Pseudomonas ventilator-associated pneumonia.Intensive Care Med. 2006 Dec;32(12):1970-8. doi: 10.1007/s00134-006-0355-7. Epub 2006 Sep 7. Intensive Care Med. 2006. PMID: 16957901 Clinical Trial.
-
Comparison of severity of illness scoring systems for patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa.BMC Infect Dis. 2006 Aug 17;6:132. doi: 10.1186/1471-2334-6-132. BMC Infect Dis. 2006. PMID: 16916466 Free PMC article.
-
Screening for Gram-negative bacteria: Impact of preanalytical parameters.Sci Rep. 2016 Jul 27;6:30427. doi: 10.1038/srep30427. Sci Rep. 2016. PMID: 27460776 Free PMC article.
-
Assessing Rates of Co-Resistance and Patient Outcomes in Multidrug-Resistant Pseudomonas aeruginosa.Microbiol Spectr. 2022 Oct 26;10(5):e0233622. doi: 10.1128/spectrum.02336-22. Epub 2022 Aug 25. Microbiol Spectr. 2022. PMID: 36005836 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources